Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma

We aimed to develop and validate a pyradiomics model for preoperative prediction of initial treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). To this end, computed tomography (CT) images were acquired from multi-centers. Numerous pyradiomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jie, Lu, Fangyang, Huang, Jinhua, Zhang, Jing, Gong, Wuxing, Hu, Yong, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618693/
https://www.ncbi.nlm.nih.gov/pubmed/36324581
http://dx.doi.org/10.3389/fonc.2022.853254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618693/
https://www.ncbi.nlm.nih.gov/pubmed/36324581
http://dx.doi.org/10.3389/fonc.2022.853254

Ejemplares similares